San Clemente, California, United States
Contact Info
2K followers
500+ connections
About
Articles by Aaron
-
Emflaza: The bigger issue beyond the headlines
Emflaza: The bigger issue beyond the headlines
By Aaron Davis
Activity
-
Super excited to have won the ADA Innovation Challenge, still buzzing
Super excited to have won the ADA Innovation Challenge, still buzzing
Liked by Aaron Davis
-
Whether you are a consultant selling into a client, or a biopharma company selling to stakeholders, there are three distinct stages in which you have…
Whether you are a consultant selling into a client, or a biopharma company selling to stakeholders, there are three distinct stages in which you have…
Liked by Aaron Davis
-
Very interesting angle here. Modular Medical, Inc. is working with Gubra to investigate basal + bolus pump delivery of a short-acting peptide as an…
Very interesting angle here. Modular Medical, Inc. is working with Gubra to investigate basal + bolus pump delivery of a short-acting peptide as an…
Liked by Aaron Davis
Experience & Education
Publications
-
Pilot Baseline Results from DeviceChoices.com, a Diabetes Device Patient Registry
Diabetes Technology Society Annual Meeting 2014
Assess the feasibility of a web-based patient registry to collect and evaluate data about diabetes device utilization in a real-world setting. During the pilot period, the DeviceChoices diabetes device patient registry platform demonstrated the ability to collect important data about the real world patient experience of those using insulin pumps and continuous glucose monitoring. The pilot baseline data characterizes insulin pump using patients with data not previously available. Further…
Assess the feasibility of a web-based patient registry to collect and evaluate data about diabetes device utilization in a real-world setting. During the pilot period, the DeviceChoices diabetes device patient registry platform demonstrated the ability to collect important data about the real world patient experience of those using insulin pumps and continuous glucose monitoring. The pilot baseline data characterizes insulin pump using patients with data not previously available. Further expansion of the DeviceChoices platform will increase the understanding of the value specific devices contribute to diabetes management.
Other authorsSee publication -
The Clinical and Economic Burden to Managed Care Organizations of Medication Non-Compliance in Cardiovascular Disease and Diabetes
California Association of Physician Groups Health Magazine
Projects
Languages
-
Spanish
-
More activity by Aaron
-
Important analysis and development in the drug pricing debate coming out of the FTC this week. Given it took 71 pages to explain the complexity of…
Important analysis and development in the drug pricing debate coming out of the FTC this week. Given it took 71 pages to explain the complexity of…
Liked by Aaron Davis
-
At this year's ADA annual conference, Spotlight AQ won the Innovation Award. I sat down with the group's Chief Science Officer and Co-Founder…
At this year's ADA annual conference, Spotlight AQ won the Innovation Award. I sat down with the group's Chief Science Officer and Co-Founder…
Liked by Aaron Davis
-
🌟 Exciting News! 🌟 I am thrilled to share that I have been selected as the first participant in Scribe Therapeutics' brand-new Rotational…
🌟 Exciting News! 🌟 I am thrilled to share that I have been selected as the first participant in Scribe Therapeutics' brand-new Rotational…
Liked by Aaron Davis
-
Come over to booth 821 and learn about the twiist AID system powered by Tidepool! #sequel #automatedinsulindelivery
Come over to booth 821 and learn about the twiist AID system powered by Tidepool! #sequel #automatedinsulindelivery
Liked by Aaron Davis
-
The CamAPS FX algorithm has received market authorisation from the United States Food and Drug Administration (FDA). Ypsomed congratulates its…
The CamAPS FX algorithm has received market authorisation from the United States Food and Drug Administration (FDA). Ypsomed congratulates its…
Liked by Aaron Davis
-
Not a novel concept, but please…bring Access into the trial design conversation as early as possible! #ClinicalTrialDesign…
Not a novel concept, but please…bring Access into the trial design conversation as early as possible! #ClinicalTrialDesign…
Liked by Aaron Davis
-
Come by booth #821 to learn more about #twiist! See you in Orlando.
Come by booth #821 to learn more about #twiist! See you in Orlando.
Liked by Aaron Davis
-
Joining our Boston office, Stratevi welcomes Laura and Uzma! Laura, a Sr. Research Associate, comes to us with an MPA from Brown and 5 years of ICER…
Joining our Boston office, Stratevi welcomes Laura and Uzma! Laura, a Sr. Research Associate, comes to us with an MPA from Brown and 5 years of ICER…
Liked by Aaron Davis
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Aaron Davis in United States
1511 others named Aaron Davis in United States are on LinkedIn
See others named Aaron Davis